A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol)

BACKGROUND: Paclitaxel is a standard of care for patients with primary cutaneous angiosarcoma of the scalp and face. However, no standard second-line treatment for paclitaxel-resistant patients has ever been established. Since primary cutaneous angiosarcoma expresses a high level of vascular endothe...

Descripción completa

Detalles Bibliográficos
Autores principales: Oashi, Kohei, Shibata, Taro, Namikawa, Kenjiro, Takahashi, Akira, Yokota, Kenji, Nakano, Eiji, Teramoto, Yukiko, Tsutsumida, Arata, Maeda, Taku, Yamazaki, Naoya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359578/
https://www.ncbi.nlm.nih.gov/pubmed/32660439
http://dx.doi.org/10.1186/s12885-020-07136-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7359578/
https://www.ncbi.nlm.nih.gov/pubmed/32660439
http://dx.doi.org/10.1186/s12885-020-07136-1

Ejemplares similares